NCEL
NewcelX Ltd.
NASDAQ: NCEL · HEALTHCARE · BIOTECHNOLOGY
$3.42
+2.09% today
Updated 2026-04-29
Market cap
$17.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.93
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
NewcelX Ltd. (NCEL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-155.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-6.66M | — | — | — |
| 2018 | — | $-5146.00 | — | — | — |
| 2019 | — | $-5.45M | — | — | — |
| 2020 | — | $-2.86M | — | — | — |
| 2021 | $0.00 | $-11.95M | — | — | — |
| 2022 | $0.00 | $-16.50M | — | — | — |
| 2023 | $0.00 | $-12.17M | — | — | — |
| 2024 | $0.00 | $-1.98M | — | — | — |